BLOG/🇺🇸United States/ma activity··daily

US Merger & Acquisition SEC Filings — April 24, 2026

USA M&A & Takeover Activity

11 high priority11 total filings analysed

Executive Summary

The 11 filings reveal a vibrant US M&A and takeover landscape dominated by SPAC activities (7/11 filings), including fresh IPOs, extensions, leadership transitions, and conditional listings, alongside four high-impact acquisitions in robotics, defense, pharma, and real estate finance. Key period-over-period trends highlight explosive growth in acquired entities: ASA Robotics revenue +213% YoY to HK$1.6M with margins expanding +5040 bps to 60.5%, Ondas backlog surging 160% to $457M pro forma, and Apollo CRE realizing $2.2B cash post-portfolio sale at a premium to trading levels. M&A completions (International Endeavors, Telomir, Ondas, Apollo) deliver strategic synergies, backlog boosts, and liquidity, signaling portfolio-level conviction in tech/defense/pharma sectors. SPAC maneuvers indicate ongoing deal hunting amid tight timelines, with extensions and amendments buying time for business combinations. Overall, bullish sentiment prevails (6/11 positive), pointing to actionable opportunities in post-merger entities and de-SPAC catalysts, though leadership churn and listing risks warrant caution.

Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from April 17, 2026.

Investment Signals(11)

  • Fresh SPAC IPO raised $60M at $10/share (plus $3M private placement), trust at $62.4M with 24-month BC window, no operations yet

  • Acquired 60% of ASA Robotics for $641K (6,500 pref shares at $98.62), target revenue +213% YoY to HK$1.6M, margins +5040 bps to 60.5%

  • Sold $9B CRE portfolio to Athene, yielding $2.2B cash and $12.05 BV/share premium to recent trading, mgmt fee cut 50% in shares for alignment

  • Completed TELI acquisition issuing 34.4M shares, consolidates Telomir-1 rights globally, $1M cash at close +$4M milestone funding commitment

  • $175M merger with Mistral adds $264M backlog (total pro forma $457M, +160% from $177M standalone), access to $1B+ US Army IDIQ vehicles

  • $50K trust deposit extends BC deadline to May 22, 2026 (from Apr 22), up to Jan 2027 possible, WISeSat target intact

  • Amended transfer delays SPV purchase of 1.27M founder shares/1.1M warrants to 6 months post-BC with Boost Run, sponsor potential 10.1M Pubco shares

  • Nasdaq continued listing granted, transfer to Capital Market Apr 24, conditional on Oabay BC by Jun 19

  • Added independent director Jae Hyun Park (SPAC/capital markets expert), bolstering audit committee ahead of 24-month BC window

  • Seamless CEO transition to Troy Rillo (experienced Yorkville partner/CFO), no disputes

  • CEO shift to Troy Rillo (multi-SPAC CFO), extensive finance background, no disagreements

Risk Flags(8)

Opportunities(8)

Sector Themes(6)

  • SPAC Extensions & Maneuvers (6/11 filings)

    4 SPACs (Columbus, Bayview, Willow Lane, JATT II) extended timelines or amended terms (e.g., monthly $50K deposits, 6-month delays), buying time amid active BC pursuits; implies sector resilience but deal delays vs peers

  • Leadership Churn in SPACs

    3/7 SPACs (Yorkville, Texas Ventures, Inflection Point) saw CEO resignations/appointments or new directors; Yorkville/Texas share Rillo transition, signaling Yorkville Advisors network consolidation

  • Explosive Growth in Acquired Tech/Defense

    Targets like ASA Robotics (+213% YoY revenue, +5040 bps margins) and Mistral/Ondas (+160% backlog to $457M) outperform standalone metrics, highlighting M&A for scale in robotics/autonomous systems

  • Liquidity Events in Finance/RE

    Apollo's $9B portfolio sale to $2.2B cash (premium BV) vs SPAC trust builds (e.g., JATT $62M); trend toward monetization/alignment (50% fee cut in shares)

  • Pharma/Robotics M&A Consolidation

    Telomir/International filings consolidate IP/rights (Telomir-1 global, ASA 60% control), with milestone funding ($4M) tying to FDA/clinical catalysts

  • Neutral/Mixed SPAC Sentiment Dominates

    5/7 SPACs neutral/mixed due to risks (delays, conditions), but positive completions (e.g., Ondas) lift portfolio averages

Watch List(7)

  • Shareholder vote on Boost Run BC Apr 30, 2026; monitor SPV transfer execution post-close [Apr 30, 2026]

  • Oabay business combination required by Jun 19 for Nasdaq compliance; delisting risk if missed [Jun 19, 2026]

  • $50K deposit due May 22 for further extension toward WISeSat BC; track monthly contributions [May 22, 2026]

  • Apollo CRE/Strategy Update
    👁

    New CRE strategy announcement or board alternatives (incl. dissolution) by year-end 2026 [Dec 31, 2026]

  • $4M funding from Bayshore on FDA IND acceptance and Phase 1/2 start for Telomir-1 [TBD 2026]

  • Underwriters' 45-day option for 900K shares post-Apr 20 IPO; trust growth potential [~Jun 4, 2026]

  • Inflection Point Acq Corp III/Annual Meeting
    👁

    Director Park term ends at 2nd stockholder meeting; BC within 24 months [TBD 2027]

Filing Analyses(11)
JATT II Acquisition Corp.8-Kpositivemateriality 9/10

24-04-2026

JATT II Acquisition Corp, a blank check company, consummated its initial public offering on April 20, 2026, selling 6,000,000 ordinary shares at $10.00 per share for gross proceeds of $60,000,000, with underwriters holding a 45-day option for an additional 900,000 shares. Simultaneously, it completed a private placement of 300,000 shares to sponsor JATT Ventures II L.P. for $3,000,000. As of April 20, 2026, total assets stood at $62,400,000, including $60,000,000 in the trust account, with no operations commenced yet and a 24-month window to complete a business combination.

  • ·Accrued offering costs: $401,910; Accrued expenses: $90,984; Over-allotment liability: $47,288; Promissory note – related party: $106,141 as of April 20, 2026.
  • ·Ordinary shares subject to possible redemption: 6,000,000 shares at $10.00 per share totaling $60,000,000.
  • ·Shareholders’ deficit: ($46,323) as of April 20, 2026.
  • ·Up to 225,000 ordinary shares subject to forfeiture depending on underwriters’ over-allotment exercise.
  • ·24 months from IPO closing to complete initial business combination.
Willow Lane Acquisition Corp.8-Kneutralmateriality 8/10

24-04-2026

Willow Lane Acquisition Corp. entered into an Amended and Restated Transfer Agreement on April 24, 2026, delaying the SPV's purchase of 27.5% of the Sponsor's 4,628,674 Founder Shares (1,272,885 shares) and 4,007,222 Private Warrants (1,101,986 warrants) at $1.75 per Founder Share from immediately prior to Closing to within six months post-Closing of the Business Combination with Boost Run Inc. This update supplements disclosures in the Proxy Statement ahead of the extraordinary general shareholder meeting on April 30, 2026. No financial performance metrics are reported, with the amendment placing Transfer Securities in escrow pending purchase.

  • ·Extraordinary general meeting of shareholders scheduled for April 30, 2026 to approve Business Combination.
  • ·Proxy Statement filed April 9, 2026, supplemented by these disclosures.
  • ·Potential Sponsor holdings post-Closing: up to 10,135,896 Pubco Class A Common Stock equivalents assuming no SPV purchase and max Working Capital Loan conversion.
  • ·Indirect Founder Share interests: George Peng (101,250), Marjorie Hernandez (45,000), Mauricio Orellana (35,000), Robert Stevens (50,000), Rayne Steinberg (35,000).
International Endeavors Corp8-Kpositivemateriality 9/10

24-04-2026

ModuLink Inc. completed the acquisition of a 60% controlling equity interest in ASA Robotics Limited on April 23, 2026, for aggregate consideration of US$641,026 through issuance of 6,500 shares of preferred stock at US$98.62 per share. ASA Robotics demonstrated strong financial performance for the year ended March 31, 2026, with revenue of HK$1.6 million (213% YoY growth from HK$0.5 million) and gross profit of HK$1.0 million (up from HK$0.1 million), improving gross margin to 60.5% from 10.1%. The deal enhances ModuLink's robotics and automation capabilities in Asia-Pacific, complementing its Luna AI healthcare initiative.

  • ·ASA Robotics board will be reconstituted post-acquisition.
  • ·Remaining 40% equity held by minority shareholders including university-affiliated entity.
  • ·Parties to finalize updated shareholders’ agreement for governance.
Yorkville Acquisition Corp.8-Kneutralmateriality 8/10

24-04-2026

On April 22, 2026, Kevin McGurn resigned as Chief Executive Officer and director of Yorkville Acquisition Corp., effective immediately, with no disputes or disagreements noted. The board appointed Troy Rillo, the existing Chief Financial Officer, as the new CEO effective immediately. Rillo, 57, has extensive experience in corporate finance, securities law, and investment management from roles at Yorkville Advisors and other firms.

  • ·Mr. Rillo has served as CFO since August 2025.
  • ·Mr. Rillo serves as CFO of Texas Ventures Acquisition III Corp since September 2025 and Blue Water Acquisition Corp. III since November 2025.
  • ·No compensatory arrangements, family relationships, or new material contracts related to Mr. Rillo's appointment.
Texas Ventures Acquisition III Corp8-Kneutralmateriality 7/10

24-04-2026

On April 22, 2026, Kevin McGurn resigned as Chief Executive Officer of Texas Ventures Acquisition III Corp, effective immediately, with no dispute or disagreement cited. The board appointed Troy Rillo, who has served as CFO since September 2025, as the new CEO effective immediately, while he continues as CFO. Rillo brings extensive experience from Yorkville Advisors and prior roles, including as CFO of Yorkville Acquisition Corp. since August 2025 and Blue Water Acquisition Corp. III since November 2025.

  • ·Mr. Rillo, age 57, is a partner at Yorkville Advisors since 2004 and Co-CEO of Yorkville Securities LLC.
  • ·No family relationships, arrangements, or new compensatory plans related to Mr. Rillo's appointment.
  • ·Mr. Rillo admitted to practice law in New Jersey and Florida; J.D. and B.S. in Finance from University of Florida.
Columbus Acquisition Corp/Cayman Islands8-Kpositivemateriality 6/10

24-04-2026

Columbus Acquisition Corp, a Cayman Islands SPAC, deposited $50,000 into its Trust Account on April 20, 2026, extending the deadline to complete its initial business combination from April 22, 2026, to May 22, 2026. The deposit was split evenly, with $25,000 from the company's working capital and $25,000 contributed by WISeSat.Space Corp., the proposed target under the Business Combination Agreement dated November 9, 2025. Further monthly extensions are possible up to January 22, 2027, upon additional $50,000 deposits.

  • ·Charter allows extensions up to January 22, 2027 via monthly $50,000 deposits
  • ·Business Combination Agreement dated November 9, 2025
Bayview Acquisition Corp8-Kmixedmateriality 8/10

24-04-2026

Bayview Acquisition Corp's securities were transferred to The Nasdaq Capital Market effective April 24, 2026, following a Nasdaq Hearings Panel decision granting continued listing after an appeal of a delisting notice. The continued listing is conditional on closing the business combination with Oabay Inc. by June 19, 2026, and demonstrating compliance with Nasdaq's initial listing rules, with no assurance of success and potential for Panel reconsideration. The transfer is not expected to materially impact trading, which continues under symbols BAYA, BAYAU, and BAYAR.

  • ·Nasdaq delisting notice received February 19, 2026
  • ·Application to transfer listing submitted December 16, 2025
  • ·Hearing conducted March 31, 2026
  • ·Panel Decision issued April 22, 2026
  • ·Option to appeal to Nasdaq Listing and Hearing Review Council within 15 days
Apollo Commercial Real Estate Finance, Inc.8-Kpositivemateriality 10/10

24-04-2026

Apollo Commercial Real Estate Finance, Inc. (ARI) completed the sale of its $9 billion commercial real estate loan portfolio to Athene Holding Ltd., following approval from a majority of stockholders at a special meeting on April 21, 2026. After repaying financing facilities, indebtedness, and expenses, ARI's total assets will consist primarily of $2.2 billion in cash, equating to a book value per share of $12.05, delivering a premium to recent stock trading levels. Management is evaluating new commercial real estate strategies with the annual management fee reduced by 50% and paid in shares for alignment, but if no new strategy is announced by year-end, the board will explore alternatives including dissolution.

  • ·Definitive agreement for sale announced on January 28, 2026.
  • ·BofA Securities served as independent financial advisor to ARI's special committee.
  • ·Fried, Frank, Harris, Shriver & Jacobson LLP served as independent legal advisor to ARI's special committee.
  • ·Stockholder special meeting held on April 21, 2026.
Inflection Point Acquisition Corp. III8-Kneutralmateriality 4/10

24-04-2026

On April 24, 2026, Inflection Point Acquisition Corp. III appointed Jae Hyun (James) Park as a Class II director and member of the Audit Committee, determining him to be independent under Nasdaq and SEC rules. Mr. Park, 59, has extensive experience in SPACs, capital markets, natural resources, and previously served at Keystone Acquisition Corp., USA Rare Earth, and KPMG. The company entered into standard indemnity and letter agreements with him, with no arrangements, family relationships, or material interests disclosed.

  • ·Mr. Park's term expires at the Company’s second annual meeting of stockholders.
  • ·Business Combination must be consummated within 24 months from Public Offering closing or extended by shareholders.
  • ·No arrangements or understandings for Mr. Park's selection; no family relationships or material interests under Item 404(a).
Telomir Pharmaceuticals, Inc.8-Kpositivemateriality 9/10

24-04-2026

Telomir Pharmaceuticals, Inc. completed its acquisition of TELI Pharmaceuticals, Inc. on April 22, 2026, issuing 34,389,710 restricted shares of common stock to TELI's former shareholders based on independent valuations. Bayshore Trust contributed $1 million at closing and entered a Commitment Agreement for up to $4 million upon milestones including FDA IND acceptance and Phase 1/2 clinical study initiation for Telomir-1. The transaction consolidates global rights to the Telomir-1 (Telomir-Zn) platform under a single entity, eliminating prior geographic fragmentation.

  • ·Transaction approved by shareholders on March 23, 2026
  • ·Shares issued in reliance on Section 4(a)(2) of Securities Act and Rule 506
  • ·Commitment Agreement dated April 20, 2026 (Exhibit 10.1)
Ondas Holdings Inc.8-Kpositivemateriality 9/10

24-04-2026

Ondas Holdings Inc. (ONDS) completed its $175 million merger with Mistral Inc., a U.S. defense prime contractor, adding $264 million in contracted backlog from Mistral and establishing direct access to U.S. Army and Special Operations IDIQ contract vehicles with programs exceeding $1 billion. This boosts Ondas' pro forma backlog to $457 million as of March 31, 2026, adjusted for Mistral and the prior World View acquisition, up from Ondas' standalone backlog of $177 million (a 160% increase from $68 million at December 31, 2025). The transaction enhances U.S.-based manufacturing and positions Ondas as a next-generation defense prime for autonomous systems deployment.

  • ·Merger includes inducement grants of 1,245,263 RSUs vesting over three years to 58 new employees under Nasdaq Rule 5635(c)(4).

Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 11 filings

More from: US Merger & Acquisition SEC Filings

🇺🇸 More from United States

View all →